VIM and hepatocellular carcinoma: Our in vivo experiments revealed that tumors derived from SORT1-silenced HCC cells exhibited reduced staining of angiogenesis markers, including CD31 and VEGF, as well as and the EMT marker Vimentin, in both subcutaneous and orthotopic xenograft models.